Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or ...

TB anywhere is TB everywhere,” said tuberculosis expert Philip Hopewell, MD, in the latest ATS Breathe Easy podcast. The U.S. has one of the lowest incidence rates of TB in the world, yet in January, ...

There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...

Sponsored by Gilead Sciences Racial and ethnic disparities in health care have long been a problem in the U.S.1 For many ...

Black Americans face higher rates and lower survival. Research explores biological, social factors, and disparities.